Key statistics
As of last trade Zimmer Biomet Holdings Inc (ZBH:NYQ) traded at 110.48, 8.88% above its 52-week low of 101.47, set on Oct 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 110.40 |
---|---|
High | 110.64 |
Low | 109.09 |
Bid | 110.38 |
Offer | 110.53 |
Previous close | 110.50 |
Average volume | 1.42m |
---|---|
Shares outstanding | 199.07m |
Free float | 198.79m |
P/E (TTM) | 21.05 |
Market cap | 22.00bn USD |
EPS (TTM) | 5.25 USD |
Annual div (ADY) | 0.96 USD |
---|---|
Annual div yield (ADY) | 0.87% |
Div ex-date | Sep 30 2024 |
Div pay-date | Oct 31 2024 |
Data delayed at least 15 minutes, as of Dec 03 2024 16:59 GMT.
More ▼
- Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
- Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
- Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
- Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
- Zimmer Biomet to Present at Jefferies London Healthcare Conference
- Zimmer Biomet Announces Third Quarter 2024 Financial Results
- Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
- Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
- Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
More ▼